Details for New Drug Application (NDA): 202857
✉ Email this page to a colleague
The generic ingredient in DAPTOMYCIN is daptomycin. There are ten drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for 202857
Tradename: | DAPTOMYCIN |
Applicant: | Hospira |
Ingredient: | daptomycin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 202857
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 500MG/VIAL | ||||
Approval Date: | Sep 12, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription